Searchicon: search

New Patient Enrollment

Receive a free starter vial of Vetsulin® for newly diagnosed pets!

ORDER NOW

Dear veterinary professional

Thank you for your continued loyalty! As a show of appreciation and support, we’re offering registered participants of this exclusive program the opportunity to provide a free starter vial of Vetsulin to patients newly diagnosed with pet diabetes.

Just follow the steps below:

Provide a vial of Vetsulin from your stock to the pet parent at the time of diagnosis.

Enter your patient’s information in the adjacent form.

Receive a replacement vial from Merck Animal Health within 6 weeks.

Bookmark this page to enroll your newly diagnosed diabetic patients.

Not a member of the program?

Contact your Merck Animal Health Representative for more information.

Diagnosed Pet Enrollment Form

Please enter the pet owner information belown.
‘*’ Denotes required fields.

Vetsulin Professional Resources

Take advantage of patient and practice resources, such as the Customized Discharge Forms. These easy-to-use forms help you provide clients with clear instructions for Vetsulin dosing and information.

Terms and conditions:

The program applies only to pets newly diagnosed with diabetes mellitus and is limited to select Vetsulin customers. Clinics should supply a vial from their inventory to the pet parent. Merck Animal Health will ship a replacement vial to your clinic. Customers should allow up to 6 weeks for product delivery.

Privacy Policy:

Information submitted is subject to the Privacy Policy stated on the Company’s Website. To read the Privacy Policy, visit: https://msdprivacy.com/us/en/index.html

Important Safety Information:

VETSULIN® and VETPEN® are for use in animals only. Dogs and cats known to have an allergy to pork or pork products should not be treated with VETSULIN®. VETSULIN® is contraindicated during periods of hypoglycemia. Animals with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy before use. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential. Overdosage can result in profound hypoglycemia and death. Progestogen and glucocorticoid use should be avoided. The safety and effectiveness of VETSULIN® in puppies, kittens, breeding, pregnant, and lactating dogs and cats has not been evaluated. Keep out of reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for at least 15 minutes. Accidental injection may cause clinical hypoglycemia. In case of accidental injection, seek medical attention immediately. Exposure to the product may induce a local or systemic allergic reaction in sensitized individuals. For complete safety information, refer to the product label.

References

  1. Martin GJ, Rand JS. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy. J Feline Med Surg. 2001;3(1):23–30. 
  2. Vetsulin® (porcine insulin zinc suspension) [Freedom of Information Summary]. Millsboro, DE: Intervet Inc.; 2008. 
  3. Data on file, Merck Animal Health. 
  4. Graham PA, Nash AS, McKellar QA. Pharmacokinetics of porcine insulin zinc suspension in diabetic dogs. J Small Anim Pract. 1997;38(10):434–438. 
  5. Martin GJ, Rand JS. Pharmacokinetic and Pharmacodynamic Study of Caninsulin in Cats with Diabetes Mellitus. 2000: Internal Study Report. 6. Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction. 3rd ed. St. Louis, MO: Saunders; 2004:539–579. 
  6. Tennant B, ed. BSAVA Small Animal Formulary. 4th ed. Gloucestershire, UK: British Small Animal Veterinary Association; 2002. 
  7. Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction. 3rd ed. St. Louis, MO: Saunders; 2004:486–538. 
  8. Reusch C. Feline diabetes mellitus. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders; 2010:1796–1816. 
  9. Nelson RW. Canine diabetes mellitus. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders; 2010:1782–1796. 
  10. Burgaud S, Riant S, Piau N. Comparative laboratory evaluation of dose delivery using a veterinary insulin pen. In: Proceedings of the WSAVA/FECAVA/BSAVA congress; 12–15 April 2012; Birmingham, UK. Abstract 121. 
  11. Burgaud S, Guillot R, Harnois-Milon G. Clinical evaluation of a veterinary insulin pen in diabetic dogs. In: Proceedings of the WSAVA/ FECAVA/BSAVA congress; 12–15 April 2012; Birmingham, UK. Abstract 122.
  12. Burgaud S, Guillot R, Harnois-Milon G. Clinical evaluation of a veterinary insulin pen in diabetic dogs. In: Proceedings of the WSAVA/ FECAVA/BSAVA congress; 12–15 April 2012; Birmingham, UK. Abstract 122. 
  13. Burgaud S, Guillot R, Harnois-Milon G. Clinical evaluation of a veterinary insulin pen in diabetic cats. In: Proceedings of the WSAVA/FECAVA/BSAVA congress; 12–15 April 2012; Birmingham, UK. Abstract 45. 
  14. Davison LJ, Walding B, Herrtage ME, Catchpole B. Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations. J Vet Intern Med. 2008;22:1317-1325. 
  15. Banfield State of Pet Health 2016 Report. p 12-13.